powered by centersite dot net
Medications
Resources
Basic InformationLatest News
3MR Intervention Effective for Discontinuing Inappropriate MedsDoes a Drug's High Price Tag Cause Its Own Side Effects?Commercialization of Generics Impacts Adverse Event RatesProcess Promising for On-Site Printing of Custom-Dosed MedsHealth Tip: Medication Use After a Natural DisasterFew Older Patients Aware of DeprescribingHealth Tip: Medication Suggestions for Older AdultsPhysicians Tweeting About Drugs May Have Conflict of InterestWhite Kids More Likely to Get Unneeded AntibioticsNew Cholesterol Drugs Vastly Overpriced, Study ContendsFDA May Limit 'Risk Info' in Direct-to-Consumer TV Drug AdsHealth Tip: Throwing Out Leftover MedicineFDA Announces Recall of Some Liquid Pharmaceutical ProductsIs FDA Taking Close Enough Look at Fast-Tracked Drugs?U.S. Antidepressant Use Jumps 65 Percent in 15 YearsThe Fine Print on Medication Expiration DatesAmericans Taking More Prescription Drugs Than Ever: SurveyInappropriate Med Use High in Cognitively Impaired SeniorsA Reminder That Meds and Grapefruit Don't Always MixAspirin Responsiveness Can Change After Bariatric SurgerySome Medicines Boost Sensitivity to SunPainkiller Prescriptions More Prone to Errors If HandwrittenMedication Mistakes Have Doubled in U.S. Since 2000: StudyMarket Competition Linked to Change in Generic Drug PricesIs Your Child's 'Penicillin Allergy' Real?FDA Seeks to Increase Number of Generic Drugs on MarketWhen Is an Opioid Safe to Take?Lifesaving Drugs From Pfizer in Short Supply: FDALeading U.S. Doctors' Group Takes Aim at Rising Drug PricesU.S. Hospitals Still Prescribe Too Many Antibiotics: StudyBirth Control Pills Recalled Due to Danger of Unintended PregnancyNew Drugs Show Promise as First to Prevent MigraineMedication Adherence Up With Refill Synchronization ModelModified Vancomycin May Help Fight Bacterial ResistanceScientists Tweak Antibiotic to Boost Power Against 'Superbugs'New Cholesterol Fighting Meds Target Key GeneResearchers Say PDE5 Inhibitors Don't Cause MelanomaNearly a Third of Drugs Hit by Safety Issues After FDA ApprovalU.S. Moves to Avert Shortage of Yellow Fever VaccineOpioid Use by Iraq, Afghanistan War Vets Mirrors Rest of U.S.: StudyApril 29 Is National Prescription Drug Take Back DayERs Administering More Medications IntranasallyFDA Warns Against Children Taking Codeine, TramadolPhysicians Finding Ways to Work Around Cost of Rx MedicationsRuling Out Penicillin Allergy by Testing Inpatients Saves MoneyEpiPen Out-of-Pocket Costs More Than Doubled Over DecadeAACR: Regular Aspirin Use Linked to Lower Cancer MortalityFDA Approves Noctiva Nasal Spray for Nocturnal PolyuriaFDA Approves Odactra for House Dust Mite AllergiesHow Much Melatonin Is Really in That Supplement?
Questions and AnswersVideosLinksBook Reviews
Related Topics

Anxiety Disorders
Depression: Depression & Related Conditions
Mental Disorders
Mental Health Professions

Researchers Say PDE5 Inhibitors Don't Cause Melanoma


HealthDay News
Updated: May 19th 2017

new article illustration

FRIDAY, May 19, 2017 (HealthDay News) -- Use of phosphodiesterase type 5 (PDE5) inhibitors does not appear to increase the risk of melanoma, according to the conclusions of a meta-analysis published online May 19 in the Journal of the National Cancer Institute.

Stacy Loeb, M.D., a urologist and assistant professor at the NYU Langone Medical Center in New York City, and colleagues analyzed data from five large-scale studies of 866,049 men who used PDE5 inhibitors.

While users had an overall 11 percent increased risk of melanoma, there wasn't evidence that the drugs cause melanoma. The link appears due to detection bias, the researchers said in an NYU news release, as men likely to take erectile medications tend to be more health-conscious, more likely to see a doctor, and therefore more likely to get diagnosed with melanoma than other men of similar age.

"Physicians should still screen for melanoma risk, but they do not need to add the use of Viagra and similar drugs to the list of screening criteria specifically," Loeb said in the news release.

Abstract/Full Text